Doerner T - Search Results

1

Intramuscular human interferon-beta injections in treatment of condylomata acuminata.

Schonfeld A, Nitke S, Schattner A, Wallach D, Crespi M, Hahn T, Levavi H, Yarden O, Shoham J, Doerner T, et al. Schonfeld A, et al. Among authors: doerner t. Lancet. 1984 May 12;1(8385):1038-42. doi: 10.1016/s0140-6736(84)91450-8. Lancet. 1984. PMID: 6143975 Clinical Trial.

2

Placebo-controlled trial of topical interferon in labial and genital herpes.

Glezerman M, Lunenfeld E, Cohen V, Sarov I, Movshovitz M, Doerner T, Shoham J, Revel M. Glezerman M, et al. Among authors: doerner t. Lancet. 1988 Jan 23;1(8578):150-2. doi: 10.1016/s0140-6736(88)92723-7. Lancet. 1988. PMID: 2892991 Clinical Trial.

3

Topical application of human fibroblast interferon (IFN) in cutaneous leishmaniasis.

Trau H, Schewach-Millet M, Shoham J, Doerner T, Shor R, Passwell JH. Trau H, et al. Among authors: doerner t. Isr J Med Sci. 1987 Nov;23(11):1125-7. Isr J Med Sci. 1987. PMID: 3325468 Clinical Trial.

4

Treatment of flat facial warts with interferon-beta cream.

Schoenfeld A, Ovadia J, Stein L, Levavi H, Nitke S, Doerner T, Revel M. Schoenfeld A, et al. Among authors: doerner t. J Dermatol Surg Oncol. 1987 Mar;13(3):299-301. doi: 10.1111/j.1524-4725.1987.tb03953.x. J Dermatol Surg Oncol. 1987. PMID: 3819163 No abstract available.

5

Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.

Aderka D, Levo Y, Rahmani R, Mory Y, Vaks B, Horowitz O, Doerner T, Shoham J, Wallach D, Revel M. Aderka D, et al. Among authors: doerner t. Isr J Med Sci. 1985 Dec;21(12):977-81. Isr J Med Sci. 1985. PMID: 4093298

6

[Beta-interferon for labial and genital herpes virus infection].

Glezerman M, Lunenfeld E, Doerner T, Cohen V, Sarov I, Revel M. Glezerman M, et al. Among authors: doerner t. Harefuah. 1989 Jan 15;116(2):88-90. Harefuah. 1989. PMID: 2651244 Clinical Trial. Hebrew.

7

Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon.

Leventon-Kriss S, Movshovitz M, Smetana Z, Shewach-Millet M, Doerner T, Gotlieb-Stematsky T. Leventon-Kriss S, et al. Among authors: doerner t. Med Microbiol Immunol. 1987;176(3):151-9. doi: 10.1007/BF00193896. Med Microbiol Immunol. 1987. PMID: 3037288

8

Ofatumumab versus Teriflunomide in Multiple Sclerosis.

Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.

9

Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus.

Zorn-Pauly L, von Stuckrad ASL, Klotsche J, Rose T, Kallinich T, Enghard P, Ostendorf L, Burns M, Doerner T, Meisel C, Schneider U, Unterwalder N, Burmester G, Hiepe F, Alexander T, Biesen R. Zorn-Pauly L, et al. Among authors: doerner t. Rheumatology (Oxford). 2022 Aug 3;61(8):3396-3400. doi: 10.1093/rheumatology/keab875. Rheumatology (Oxford). 2022. PMID: 34849605

10

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects.

Smolen JS, Caporali R, Doerner T, Fautrel B, Benedetti F, Pieper B, Jang M. Smolen JS, et al. Among authors: doerner t. RMD Open. 2021 Jun;7(2):e001637. doi: 10.1136/rmdopen-2021-001637. RMD Open. 2021. PMID: 34099538 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page